A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence

Clinical trial NCT01767519 · COMPLETED

Trial details

NCT number: NCT01767519
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder Urinary Incontinence

Start date: 2013-03-01
Primary completion: 2014-09-30
Enrollment: 356

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.